Why pharmacogenomics? why now?

Nature Biotechnology

Volumn 16, Issue 6, 1998, Pages 492-493

  Housman, David ^a   Ledley, Fred D ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b Variagenics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC VARIABILITY; GENOME; HUMAN; PHARMACOGENETICS; REVIEW;

GENOME, HUMAN; HUMANS; PHARMACOGENETICS; VARIATION (GENETICS);

EID: 0032091881     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0698-492     Document Type: Article

References (5)

1. Marshall, A. 1997. Nature Biotechnology 15:1249-1252.
2. Scangos, G. 1997. Nature Biotechnology 15:1220-1221.
3. Drews, J. and Ryser, S. 1997. Nature Biotechnology 15:1318-1319.
4. Jeffreys, A.J. 1979. Cell 18:1-10.
5. Propping, P. 1978. Physiol. Biochem. Pharmacol. 83:123-173.